170 related articles for article (PubMed ID: 23782236)
1. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
Masson P; Lushchekina S; Schopfer LM; Lockridge O
Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
[TBL] [Abstract][Full Text] [Related]
2. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
3. Butyrylcholinesterase-catalyzed hydrolysis of N-methylindoxyl acetate: analysis of volume changes upon reaction and hysteretic behavior.
Masson P; Froment MT; Fort S; Ribes F; Bec N; Balny C; Schopfer LM
Biochim Biophys Acta; 2002 Jun; 1597(2):229-43. PubMed ID: 12044901
[TBL] [Abstract][Full Text] [Related]
4. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
[TBL] [Abstract][Full Text] [Related]
5. Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.
Masson P; Bec N; Froment MT; Nachon F; Balny C; Lockridge O; Schopfer LM
Eur J Biochem; 2004 May; 271(10):1980-90. PubMed ID: 15128307
[TBL] [Abstract][Full Text] [Related]
6. Structural and hydration changes in the active site gorge of phosporhylated butyrylcholinesterase accompanying the aging process.
Masson P; Fortier PL; Albaret C; Cléry C; Guerra P; Lockridge O
Chem Biol Interact; 1999 May; 119-120():17-27. PubMed ID: 10421435
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
FEBS J; 2008 May; 275(10):2617-31. PubMed ID: 18422653
[TBL] [Abstract][Full Text] [Related]
8. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.
Carletti E; Schopfer LM; Colletier JP; Froment MT; Nachon F; Weik M; Lockridge O; Masson P
Chem Res Toxicol; 2011 Jun; 24(6):797-808. PubMed ID: 21438623
[TBL] [Abstract][Full Text] [Related]
9. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent kinetic complexities in cholinesterase-catalyzed reactions.
Masson P
Biochemistry (Mosc); 2012 Oct; 77(10):1147-61. PubMed ID: 23157295
[TBL] [Abstract][Full Text] [Related]
11. Understanding the non-catalytic behavior of human butyrylcholinesterase silent variants: Comparison of wild-type enzyme, catalytically active Ala328Cys mutant, and silent Ala328Asp variant.
Lushchekina S; Nemukhin A; Varfolomeev S; Masson P
Chem Biol Interact; 2016 Nov; 259(Pt B):223-232. PubMed ID: 27062896
[TBL] [Abstract][Full Text] [Related]
12. Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics.
Masson P; Schopfer LM; Froment MT; Debouzy JC; Nachon F; Gillon E; Lockridge O; Hrabovska A; Goldstein BN
Chem Biol Interact; 2005 Dec; 157-158():143-52. PubMed ID: 16256969
[TBL] [Abstract][Full Text] [Related]
13. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of pressure and temperature on the catalytic behaviour of wild-type human butyrylcholinesterase and its D70G mutant.
Weingand-Ziadé A; Renault F; Masson P
Eur J Biochem; 1999 Sep; 264(2):327-35. PubMed ID: 10491076
[TBL] [Abstract][Full Text] [Related]
15. Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase.
Liyasova MS; Schopfer LM; Lockridge O
Chem Biol Interact; 2013 Mar; 203(1):103-7. PubMed ID: 22898212
[TBL] [Abstract][Full Text] [Related]
16. Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad.
Grigorenko BL; Novichkova DA; Lushchekina SV; Zueva IV; Schopfer LM; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Chem Biol Interact; 2019 Jun; 306():138-146. PubMed ID: 31009643
[TBL] [Abstract][Full Text] [Related]
17. Specificity of ethephon as a butyrylcholinesterase inhibitor and phosphorylating agent.
Haux JE; Lockridge O; Casida JE
Chem Res Toxicol; 2002 Dec; 15(12):1527-33. PubMed ID: 12482234
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides.
Masson P; Froment MT; Gillon E; Nachon F; Darvesh S; Schopfer LM
Biochim Biophys Acta; 2007 Sep; 1774(9):1139-47. PubMed ID: 17690023
[TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters.
Masson P; Froment MT; Fortier PL; Visicchio JE; Bartels CF; Lockridge O
Biochim Biophys Acta; 1998 Sep; 1387(1-2):41-52. PubMed ID: 9748494
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]